WA pharma startup to give diabetes and rare diseases a shot in the arm
Cutting edge health research from Murdoch University takes a step closer to the clinic with the launch of ProGenis Pharmaceuticals.
Latest updates about ProGenis.
Cutting edge health research from Murdoch University takes a step closer to the clinic with the launch of ProGenis Pharmaceuticals.
ProGenis Welcomes Ms. Emily Nguyen as our Research Scientist
ProGenis Pharmaceuticals has executed into a Patent Assignment Agreement with Murdoch University, Western Australia towards developing Novel Treatment for Duchenne muscular dystrophy (DMD) and Multiple
ProGenis welcomes Mr Rohith Thamban as our ICT Business Analyst
ProGenis welcomes Dr Bao Le as our Senior Research Scientist
ProGenis welcomes Dr. Sudhir Agrawal as a new Director
Cutting edge health research from Murdoch University takes a step closer to the clinic with the launch of ProGenis Pharmaceuticals.
ProGenis Welcomes Ms. Emily Nguyen as our Research Scientist
ProGenis Pharmaceuticals has executed into a Patent Assignment Agreement with Murdoch University, Western Australia towards developing Novel Treatment for Duchenne muscular dystrophy (DMD) and Multiple
ProGenis welcomes Mr Rohith Thamban as our ICT Business Analyst
ProGenis welcomes Dr Bao Le as our Senior Research Scientist
ProGenis welcomes Dr. Sudhir Agrawal as a new Director
*By submitting your information, you are granting us permission to email you. You may unsubscribe at any time.